An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021789
Company: GALDERMA LABS LP

Products on NDA 021789

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
METROGEL	METRONIDAZOLE	1%	GEL;TOPICAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021789

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/30/2005	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021789lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021789ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021789s000_MetrogelTOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/22/2023	SUPPL-13	Labeling-Patient Package Insert, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021789s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021789Orig1s013ltr.pdf
03/16/2022	SUPPL-10	Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021789s009s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021789 Orig1s009, s010ltr.pdf
03/16/2022	SUPPL-9	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021789s009s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021789 Orig1s009, s010ltr.pdf
01/12/2015	SUPPL-6	Manufacturing (CMC)		Label is not available on this site.
09/04/2014	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
10/19/2011	SUPPL-4	Labeling	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021789s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021789s004ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021789Orig1s004.pdf
03/05/2010	SUPPL-3	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021789s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021789s003ltr.pdf
08/29/2006	SUPPL-2	Labeling-Container/Carton Labels		Label is not available on this site.
11/14/2005	SUPPL-1	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021789s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021789s001ltr.pdf

Labels for NDA 021789

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/22/2023	SUPPL-13	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021789s013lbl.pdf
11/22/2023	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021789s013lbl.pdf
03/16/2022	SUPPL-10	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021789s009s010lbl.pdf
03/16/2022	SUPPL-9	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021789s009s010lbl.pdf
10/19/2011	SUPPL-4	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021789s004lbl.pdf
03/05/2010	SUPPL-3	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021789s003lbl.pdf
11/14/2005	SUPPL-1	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021789s001lbl.pdf
06/30/2005	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021789lbl.pdf

Therapeutic Equivalents for NDA 021789

METROGEL

GEL;TOPICAL; 1%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
METROGEL	METRONIDAZOLE	1%	GEL;TOPICAL	Prescription	Yes	AB	021789	GALDERMA LABS LP
METRONIDAZOLE	METRONIDAZOLE	1%	GEL;TOPICAL	Prescription	No	AB	212646	ALEMBIC
METRONIDAZOLE	METRONIDAZOLE	1%	GEL;TOPICAL	Prescription	No	AB	216692	COSETTE
METRONIDAZOLE	METRONIDAZOLE	1%	GEL;TOPICAL	Prescription	No	AB	204651	TARO

Top